Results 151 to 160 of about 983,540 (218)

Zona ophtalmique après vaccination par Pfizer BNT162b2 et Moderna mRNA-1273 chez deux patients jeunes et immunocompétents

, 2022
M A Amblard, E Costantini, George Hayek, X Ricaud   +3 more
openalex   +2 more sources

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients

New England Journal of Medicine, 2021
Victoria G Hall, V. Ferreira, T. Ku, M. Ierullo, Beata Majchrzak-Kita, C. Chaparro, N. Selzner, J. Schiff, Michael A McDonald, G. Tomlinson, V. Kulasingam, Deepali Kumar, A. Humar   +12 more
semanticscholar   +1 more source

Replication Data for Humoral and cellular immune response over 9 months of mRNA-1273, BNT162b2 and ChAdOx1 vaccination in a University Hospital in Spain

, 2022
Gabriel Reina
openalex   +1 more source

Waning of two-dose BNT162b2 and mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection is robust to depletion-of-susceptibles bias [PDF]

, 2022
Kristin L. Andrejko, Jake M. Pry, Jennifer F. Myers, Megha Mehrotra, Katherine Lamba, Esther Lim, Nozomi Fukui, Jennifer L. DeGuzman, John J. Openshaw, James Watt, Seema Jain, Joseph A. Lewnard   +11 more
openalex   +1 more source

IgG antibody responses to SARS-CoV-2 vaccination in Manitoba, Canada [PDF]

Understanding variables that influence antibody responses to SARS-CoV-2 vaccination within a population can provide valuable information on future vaccination strategies.
Martens, Brielle
core   +1 more source

Guillian-Barrés syndrom efter mRNA-1273-COVID-19-vaccine

, 2021
Søren Kirchhoff Christensen, Martin Ballegaard, Magnus Spangsberg Boesen   +2 more
openalex   +1 more source

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial

, 2022
Hana M. El Sahly, Lindsey R. Baden, Brandon Essink, David C. Montefiori, Adrian McDermont, Richard Rupp, Michael Lewis, Shobha Swaminathan, Carl Griffin, Veronica Fragoso, Vicki E. Miller, Bethany Girard, Yamuna Devi Paila, Weiping Deng, Joanne E. Tomassini, Robert Paris, F. Schödel, Rituparna Das, Allison August, Brett Leav, Jacqueline M. Miller, Haiyu Zhou, Rolando Pajón, for the Coronavirus Efficacy (COVE) Study Group   +23 more
openalex   +2 more sources

No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial

Human Vaccines & Immunotherapeutics
The objective of the study was to assess the safety and immunogenicity of mRNA-1273 COVID-19 booster vaccination when co-administered with an egg-based standard dose seasonal quadrivalent influenza vaccine (QIV).
A. Naficy, A. Kuxhausen, Harry Seifert, Andrew Hastie, B. Leav, Jacqueline Miller, Kate Anteyi, A. Mwakingwe-Omari   +7 more
semanticscholar   +1 more source

Acute Myocarditis After COVID-19 Vaccination with mRNA-1273 in a Patient with Former SARS-CoV-2 Infection [PDF]

, 2021
Tiến Dũng Nguyễn, Gerhard Mall, Julian Westphal, Oliver Weingärtner, Sven Möbius‐Winkler, P. Christian Schulze   +5 more
openalex   +1 more source

Immunogenicity of the mRNA-1273 COVID-19 Vaccine in Patients With Inborn Errors of Immunity

, 2022
Leanne P. M. van Leeuwen, Corine H. GeurtsvanKessel, Pauline M. Ellerbroek, Godelieve J. de Bree, Judith Potjewijd, Abraham Rutgers, Hetty Jolink, Frank L. van de Veerdonk, Eric C. M. Van Gorp, Faye de Wilt, Susanne Bogers, Lennert Gommers, Daryl Geers, Anke H. W. Bruns, Helen L. Leavis, Jelle van Haga, Bregtje A. Lemkes, Annelou van der Veen, Suzanne de Kruijff, Pieter van Paassen, Karina de Leeuw, Annick van der Ven, Petra Verbeek, Annelies van Wengen, Sandra M. Arend, Anja Ruten-Budde, Marianne van der Ent, Martin van Hagen, Rogier W. Sanders, Marloes Grobben, Karlijn van der Straten, Judith A. Burger, Meliawati Poniman, Marit J. van Gils, Rory D. de Vries, Virgil A. S. H. Dalm   +35 more
openalex   +1 more source